View Post

Liquid biopsy may predict early-stage TNBC recurrence

In Clinical Studies News by Barbara Jacoby

By: Shreeya Nanda From: medwirenews.com The presence of circulating tumor (ct)DNA and circulating tumor cells (CTCs) in postsurgical samples is associated with relapse and poor outcomes in early-stage triple-negative breast cancer (TNBC) patients with an incomplete pathologic response to neoadjuvant chemotherapy, research suggests. Distant disease-free survival (DDFS), DFS, and overall survival (OS) were significantly worse for patients with versus without …

View Post

Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

In Clinical Studies News by Barbara Jacoby

Source: Indiana University School of Medicine From: technologynetworks.com Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women’s blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative …